Rhino-Orbital Mucormycosis Presenting As Orbital Apex Syndrome With Central Retinal Artery Occlusion: A Rare Phenomenon

鼻眶毛霉菌病表现为眶尖综合征伴中央视网膜动脉阻塞:一种罕见现象

阅读:1

Abstract

Rhino-orbital-cerebral mucormycosis (ROCM) is an opportunistic infection that has increased due to COVID-19 with the use of corticosteroids and diabetes being the most important predisposing factors. Orbital apex syndrome with central retinal artery occlusion secondary to mucormycosis is relatively rare. This case report highlights a case of a 62-year-old female with poorly controlled diabetes and a history of COVID-19 two weeks prior, who presented with acute right eye painful visual loss for three days associated with bulging of the right eye and drooping of the eyelid. On presentation, she had no light perception in her right eye, total ocular movement restriction, lid swelling, bulging of the eye, and complete ptosis. Examination of the right eye showed mild conjunctival redness with evidence of central retinal artery occlusion. Contrast-enhanced computed tomography of the brain and orbit revealed evidence of orbital cellulitis with sinusitis. Nasal endoscopy revealed features of fungal sinusitis. Despite multiple attempts of debridement and intravenous Amphotericin B, the patient's condition progressed and required right orbital exenteration. This report aims to highlight the necessity of high suspicion of ROCM in COVID-19 patients with diabetes, a history of steroid use, and the need to be followed up beyond recovery. Multidisciplinary team management is needed to detect red flag symptoms and signs, diagnose promptly with appropriate microbiological and radiological investigations, and initiate early treatment with antifungal and aggressive surgical debridement for a successful outcome and to prevent the need for extensive surgical measures like orbital exenteration.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。